Alicia Abalo
Santiago De Compostela, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off-the-shelf targeted NGS panel.
Journal: Molecular oncology
Published: October 25, 2025
Red blood cell-tumor cell interactions promote tumor cell progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 17, 2024
Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 09, 2024
Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer.
Journal: Molecular & cellular proteomics : MCP
Published: May 26, 2023
Noninvasive detection of microsatellite instability in patients with endometrial cancer.
Journal: International journal of cancer
Published: October 21, 2022
Rapid Idylla mutational testing to detect EGFR mutations in plasma samples and to monitor therapy in advanced non-small cell lung cancer patients.
Journal: Pathology
Published: July 23, 2022
Improving the Management of Endometrial Cancer Patients through the Use of Liquid Biopsy Analyses: A Case Report.
Journal: International journal of molecular sciences
Published: June 28, 2022
Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients.
Journal: Translational lung cancer research
Published: April 08, 2022
Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: November 08, 2021
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab.
Journal: Molecular oncology
Published: April 27, 2021
Last Updated: 09/26/2026